210 likes | 224 Views
This article explores the use of BGA monitoring to evaluate the effects of therapy on occult hypoperfusion. It discusses the importance of monitoring markers such as ScvO2, lactate, and delta PCO2. The article also highlights the relationship between lactate concentration and liver and kidney metabolism production. Additionally, it discusses the significance of early lactate clearance in improving outcomes.
E N D
….a look from inside…. in “occult” hypoperfusion ScvO2 LACTATE DELTA PCO2 …helps to evaluate therapy effects…
140 12 120 10 100 8 80 6 VO2 ml/min 60 Lactate mmol/L 4 40 2 20 0 0 0 50 100 150 200 250 300 350 400 The Supply-Dependency OER DO2 ml/min/m2
SaO2 CO ScvO2 Hb VO2
LACT & normal pH HYPERLACTATEMIA (PFK, shuttle, messenger) LACT & low pH LACTIC ACIDOSIS * Low Mitho Activity * Low ATP/ADP * High NADH/NAD * Low pHi and pHo
“instantaneous” LACTATE CONCENTRATION vs LIVER & KIDNEY METABOLISM PRODUCTION vs
x 100 EARLY LACTATE CLEARANCE IS ASSOCIATED WITH IMPROVED OUTCOME Lactate start - Lactate 6 H Lactate start NGUYEN HB, RIVERS EP (2004) CCM 32;8:1637-42
PCO2 The CO2 lung presentation & low flow A V O2 demand DO2 VO2 ATP AMP + H+ Lact- + H+ H+ + HCO3-
∆ CO2 = 9.2 ∆ CO2 = 5.3 OER = 36 OER = 33.5 FS 1993
If low = O2 debt ÷ ScvO2 + low pH = lactic acidosis + low pH = tissue acidosis ÷ ΔvaPCO2 O2 Demand VCO2 VO2 flow DO2 DO2 = the future…? ↓micro-flow ÷ ΔtaPCO2 Δva PCO2 : next ????? ΔavO2 Content
KEY POINTS Micro vs Macro Serial Lactate better (fast vs slow clearance) ScvO2 vs Delta PCO2 monitoring Perspective: Lact/Pyr, pHi, Lactate Gaps…… Think about the “FULL PICTURE”